Effect of Intranasal Anti-IgE Antibodies on IgE Production

Summary

In this study, participants will receive either intranasal anti-IgE-antibodies (n=5) or intranasal allergen (n=5) or intranasal placebo (n=5). Blood samples will be obtained before nasal administration of study drugs and 3, 5 and 8 weeks thereafter. In the serum samples, specific and total IgE levels will be assessed.

Timeline

Start

2012-11

Primary completion

2013-05

Completion

2013-05

Drugs

Indications